News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,696 Results
Type
Article (38605)
Company Profile (222)
Press Release (688041)
Multimedia
Podcasts (90)
Webinars (14)
Section
Business (230607)
Career Advice (969)
Deals (34254)
Drug Delivery (103)
Drug Development (77057)
Employer Resources (83)
FDA (16194)
Job Trends (14230)
News (338044)
Policy (30844)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2423)
Accelerated approval (45)
ADA (40)
Adcomms (13)
Allergies (198)
Alliances (51040)
ALS (207)
Alzheimer's disease (1718)
Antibody-drug conjugate (ADC) (506)
Approvals (16938)
Artificial intelligence (780)
ASCO (285)
Autoimmune disease (350)
Automation (63)
Bankruptcy (334)
Best Places to Work (11165)
BIO (62)
Biologics (2)
BIOSECURE Act (10)
Biosimilars (186)
BioSpace Insights (125)
Biotechnology (147)
Bladder cancer (211)
Brain cancer (74)
Breast cancer (783)
Cancer (6114)
Cardiovascular disease (454)
Career advice (863)
Career pathing (27)
CAR-T (350)
CDC (40)
Celiac Disease (3)
Cell therapy (927)
Cervical cancer (58)
Clinical research (68473)
Collaboration (2294)
Commercialization (7)
Company closure (3)
Compensation (1557)
Complete response letters (58)
COVID-19 (2259)
CRISPR (124)
C-suite (1295)
Cystic fibrosis (144)
Data (8697)
Decentralized trials (3)
Denatured (45)
Depression (163)
Dermatology (108)
Diabetes (619)
Diagnostics (7097)
Digital health (69)
Diversity (11)
Diversity, equity & inclusion (20)
Drug discovery (363)
Drug pricing (163)
Drug shortages (27)
Duchenne muscular dystrophy (265)
Earnings (89668)
Editorial (49)
Employer branding (12)
Employer resources (79)
Events (119858)
Executive appointments (1148)
FDA (20490)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (23)
Frontotemporal dementia (33)
Funding (1787)
Gene editing (258)
Generative AI (63)
Gene therapy (684)
GLP-1 (885)
Government (3903)
Grass and pollen (6)
Guidances (413)
Healthcare (18378)
Hematology (162)
HIV (89)
Huntington's disease (46)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (102)
Immunology and inflammation (190)
Immuno-oncology (91)
Indications (231)
Infectious disease (2603)
Inflammatory bowel disease (216)
Inflation Reduction Act (13)
Influenza (141)
Intellectual property (335)
Interviews (114)
IPO (15879)
IRA (43)
Job creations (3475)
Job search strategy (769)
JPM (31)
Kidney cancer (22)
Labor market (69)
Layoffs (334)
Leadership (16)
Legal (7579)
Licensing (11)
Liver cancer (94)
Longevity (36)
Lung cancer (826)
Lymphoma (458)
Machine learning (61)
Management (32)
Manufacturing (1078)
Marketing (11)
MASH (181)
Medical affairs (1)
Medical device (14980)
Medtech (15220)
Mergers & acquisitions (19770)
Metabolic disorders (1407)
mRNA (219)
Multiple sclerosis (188)
NASH (13)
Neurodegenerative disease (422)
Neuropsychiatric disorders (84)
Neuroscience (3243)
NextGen: Class of 2026 (6269)
Non-profit (3744)
Now hiring (53)
Obesity (561)
Opinion (207)
Ovarian cancer (237)
Pain (273)
Pancreatic cancer (327)
Parkinson's disease (369)
Partnered (31)
Patents (662)
Patient recruitment (845)
Peanut (67)
People (60162)
Pharmaceutical (48)
Pharmacy benefit managers (25)
Phase 1 (21600)
Phase 2 (30076)
Phase 3 (22017)
Pipeline (10846)
Policy (223)
Postmarket research (2438)
Preclinical (9075)
Press Release (70)
Prostate cancer (334)
Psychedelics (38)
Radiopharmaceuticals (358)
Rare diseases (1025)
Real estate (5696)
Recruiting (35)
Regulatory (25059)
Reports (33)
Research institute (2301)
Resumes & cover letters (142)
Rett syndrome (50)
RNA editing (22)
RSV (79)
Schizophrenia (171)
Series A (306)
Series B (224)
Service/supplier (7)
Sickle cell disease (103)
Special edition (10)
Spinal muscular atrophy (150)
Sponsored (35)
Startups (3709)
State (2)
Stomach cancer (14)
Supply chain (108)
Tariffs (45)
The Weekly (43)
Vaccines (987)
Venture capital (86)
Weight loss (339)
Women's health (133)
Worklife (8)
Date
Today (74)
Last 7 days (371)
Last 30 days (2253)
Last 365 days (28640)
2026 (18725)
2025 (28642)
2024 (33746)
2023 (38606)
2022 (49761)
2021 (54050)
2020 (52355)
2019 (44386)
2018 (33493)
2017 (31145)
2016 (30719)
2015 (37105)
2014 (31328)
2013 (26958)
2012 (29101)
2011 (29688)
2010 (28450)
Location
Africa (633)
Alabama (96)
Alaska (6)
Arizona (404)
Arkansas (16)
Asia (40213)
Australia (6506)
California (14512)
Canada (3983)
China (1542)
Colorado (640)
Connecticut (637)
Delaware (436)
Europe (83260)
Florida (2193)
Georgia (474)
Hawaii (4)
Idaho (65)
Illinois (1210)
India (97)
Indiana (601)
Iowa (24)
Japan (643)
Kansas (140)
Kentucky (50)
Louisiana (56)
Maine (40)
Maryland (1760)
Massachusetts (10324)
Michigan (420)
Minnesota (817)
Mississippi (7)
Missouri (171)
Montana (34)
Nebraska (29)
Nevada (146)
New Hampshire (89)
New Jersey (3756)
New Mexico (30)
New York (3761)
North Carolina (1870)
North Dakota (11)
Northern California (7284)
Ohio (435)
Oklahoma (25)
Oregon (40)
Pennsylvania (2791)
Puerto Rico (31)
Rhode Island (54)
South America (944)
South Carolina (93)
South Dakota (1)
Southern California (5894)
Tennessee (238)
Texas (2404)
United States (51133)
Utah (444)
Vermont (2)
Virginia (319)
Washington D.C. (71)
Washington State (1197)
West Virginia (4)
Wisconsin (160)
Wyoming (3)
726,696 Results for "otonexus medical technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
OtoNexus Medical Technologies Accepted into Prestigious Pediatric Medical Device Accelerator, CTIP
OtoNexus Medical Technologies Inc., is proud to announce its recent acceptance into The Consortium for Technology & Innovation in Pediatrics (CTIP).
December 12, 2023
·
2 min read
BioForest
OtoNexus Medical Technologies Selected for Elite FDA STeP Program
OtoNexus Medical Technologies is excited to announce its recent selection into U. S. Food and Drug Administration Safter Technologies Program (STeP).
December 6, 2023
·
2 min read
Business
OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directors
OtoNexus Medical Technologies, Inc. is pleased to announce the appointment of Chris Rivera to its Board of Directors.
April 4, 2023
·
2 min read
BioForest
OtoNexus Medical Technologies Honored as a Top 100 Best Place to Work in Washington State
OtoNexus Medical Technologies, a medical device innovator, is celebrating its recognition as one of Washington’s 100 Best Workplaces.
June 28, 2023
·
2 min read
Press Releases
Providence™ Medical Technology Appoints Lane Major as President & Chief Executive Officer
August 6, 2026
·
3 min read
Press Releases
MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
August 18, 2026
·
3 min read
Press Releases
Medical Care Technologies (OTC PINK:MDCE) Advances Rigorous Multi-Phase Validation of AI Imaging Platform
July 23, 2026
·
2 min read
Press Releases
Medical Care Technologies Inc. (OTC Pink:MDCE) Expands AI Commercialization Strategy with Enterprise Vision Solutions
May 11, 2026
·
2 min read
Press Releases
Medical Care Technologies Continues Rigorous Testing of MDCE Melanoma Scan While Evaluating Expansion Opportunities (OTC Pink:MDCE)
August 3, 2026
·
2 min read
Press Releases
Medical Care Technologies Demonstrates Broad Monetization Power Across AI Vision, Software Development and Digital Platforms (OTC Pink:MDCE)
August 2, 2026
·
3 min read
1 of 72,670
Next
